Since the conceptualisation of botulinum toxins types A and B (BTX-A/BTX-B) as treatments for cosmetic enhancement in 1990,1 their use has grown exponentially making botulinum toxin one of the most requested and accessible cosmetic treatments available around the world.1
As in the realms of beauty and fashion, the male market for aesthetic treatments was traditionally seen as an afterthought, lagging behind in terms of revenue and importance when compared with that of the female. Between 2000 and 2014 however, the American Association of Plastic Surgeons reported an increase of 67% of men undergoing minimally invasive non-surgical cosmetic procedures and, within this, an increase of 337% of men undergoing botulinum toxin treatments.2 This significant statistic highlights and supports the recent observations in the media that male patients are gaining significant interest in these…
